Our findings also suggest that DUOX2+ACE2+ small cholangiocytes and serum anti-pIgR autoantibody levels may be specific biomarkers for the diagnosis and evaluation of PBC, including PBC patients with negative AMAs. This evidence concerns the gene PIGR and primary biliary cholangitis.